Does the media prefer ENOV or VAC?

In the previous week, Enovis had 2 more articles in the media than Marriott Vacations Worldwide. MarketBeat recorded 9 mentions for Enovis and 7 mentions for Marriott Vacations Worldwide. Enovis' average media sentiment score of 0.36 beat Marriott Vacations Worldwide's score of -0.28 indicating that Enovis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 0 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Marriott Vacations Worldwide 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, ENOV or LIVN?

LivaNova has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enovis $2.28B 0.54 -$1.18B -$19.88 N/A LivaNova $1.43B 3.08 -$242.47M $1.95 41.22

Is ENOV or LIVN more profitable?

LivaNova has a net margin of 7.48% compared to Enovis' net margin of -49.92%. LivaNova's return on equity of 16.48% beat Enovis' return on equity. Company Net Margins Return on Equity Return on Assets Enovis -49.92% 10.32% 4.57% LivaNova 7.48% 16.48% 7.59%

Does the media prefer ENOV or LIVN?

In the previous week, Enovis had 1 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for Enovis and 8 mentions for LivaNova. LivaNova's average media sentiment score of 0.49 beat Enovis' score of 0.36 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 0 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 0 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, NVST or ENOV?

Envista has higher revenue and earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.81B 1.41 $47M $0.41 59.30 Enovis $2.28B 0.54 -$1.18B -$19.88 N/A

Is NVST or ENOV more profitable?

Envista has a net margin of 2.41% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% Enovis -49.92% 10.32% 4.57%

Does the media favor NVST or ENOV?

In the previous week, Enovis had 8 more articles in the media than Envista. MarketBeat recorded 9 mentions for Enovis and 1 mentions for Envista. Envista's average media sentiment score of 0.40 beat Enovis' score of 0.36 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enovis 0 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IRTC or ENOV?

In the previous week, Enovis had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Enovis and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.32 beat Enovis' score of 0.36 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enovis 0 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, ENOV or MMED?

MiniMed Group has higher revenue and earnings than Enovis. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enovis $2.28B 0.54 -$1.18B -$19.88 N/A MiniMed Group $2.99B 1.43 N/A N/A N/A

Is ENOV or MMED more profitable?

MiniMed Group has a net margin of 0.00% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat MiniMed Group's return on equity. Company Net Margins Return on Equity Return on Assets Enovis -49.92% 10.32% 4.57% MiniMed Group N/A N/A N/A

Does the media prefer ENOV or MMED?

In the previous week, Enovis had 6 more articles in the media than MiniMed Group. MarketBeat recorded 9 mentions for Enovis and 3 mentions for MiniMed Group. Enovis' average media sentiment score of 0.36 beat MiniMed Group's score of -0.04 indicating that Enovis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 0 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Enovis (ENOV) Competitors

$21.43 -0.54 (-2.47%)

As of 03:47 PM Eastern

Compare

ENOV vs. VAC, LIVN, NVST, IRTC, and MMED

Should you buy Enovis stock or one of its competitors? MarketBeat compares Enovis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Enovis include Marriott Vacations Worldwide (VAC), LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), and MiniMed Group (MMED).

How does Enovis compare to Marriott Vacations Worldwide?

Enovis (NYSE:ENOV) and Marriott Vacations Worldwide (NYSE:VAC) are related companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Enovis presently has a consensus price target of $44.50, indicating a potential upside of 107.68%. Marriott Vacations Worldwide has a consensus price target of $83.70, indicating a potential downside of 9.54%. Given Enovis' stronger consensus rating and higher possible upside, analysts clearly believe Enovis is more favorable than Marriott Vacations Worldwide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Marriott Vacations Worldwide	3 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.33

Marriott Vacations Worldwide has higher revenue and earnings than Enovis. Marriott Vacations Worldwide is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.28B	0.54	-$1.18B	-$19.88	N/A
Marriott Vacations Worldwide	$5.03B	0.63	-$308M	-$10.09	N/A

Enovis has a beta of 1.38, meaning that its share price is 38% more volatile than the broader market. Comparatively, Marriott Vacations Worldwide has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market.

Marriott Vacations Worldwide has a net margin of -6.72% compared to Enovis' net margin of -49.92%. Marriott Vacations Worldwide's return on equity of 11.37% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
Marriott Vacations Worldwide	-6.72%	11.37%	2.58%

98.4% of Enovis shares are owned by institutional investors. Comparatively, 89.5% of Marriott Vacations Worldwide shares are owned by institutional investors. 2.9% of Enovis shares are owned by insiders. Comparatively, 13.3% of Marriott Vacations Worldwide shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Enovis had 2 more articles in the media than Marriott Vacations Worldwide. MarketBeat recorded 9 mentions for Enovis and 7 mentions for Marriott Vacations Worldwide. Enovis' average media sentiment score of 0.36 beat Marriott Vacations Worldwide's score of -0.28 indicating that Enovis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	0 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Marriott Vacations Worldwide	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Enovis beats Marriott Vacations Worldwide on 8 of the 15 factors compared between the two stocks.

How does Enovis compare to LivaNova?

Enovis (NYSE:ENOV) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

In the previous week, Enovis had 1 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for Enovis and 8 mentions for LivaNova. LivaNova's average media sentiment score of 0.49 beat Enovis' score of 0.36 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	0 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LivaNova has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.28B	0.54	-$1.18B	-$19.88	N/A
LivaNova	$1.43B	3.08	-$242.47M	$1.95	41.22

Enovis presently has a consensus target price of $44.50, indicating a potential upside of 107.68%. LivaNova has a consensus target price of $79.38, indicating a potential downside of 1.26%. Given Enovis' higher possible upside, research analysts plainly believe Enovis is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

98.4% of Enovis shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Enovis has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

LivaNova has a net margin of 7.48% compared to Enovis' net margin of -49.92%. LivaNova's return on equity of 16.48% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
LivaNova	7.48%	16.48%	7.59%

Summary

LivaNova beats Enovis on 8 of the 15 factors compared between the two stocks.

How does Enovis compare to Envista?

Envista (NYSE:NVST) and Enovis (NYSE:ENOV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

Envista presently has a consensus target price of $28.67, indicating a potential upside of 17.90%. Enovis has a consensus target price of $44.50, indicating a potential upside of 107.68%. Given Enovis' stronger consensus rating and higher possible upside, analysts clearly believe Enovis is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Envista has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Enovis has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market.

98.4% of Enovis shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 2.9% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Envista has a net margin of 2.41% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Enovis	-49.92%	10.32%	4.57%

In the previous week, Enovis had 8 more articles in the media than Envista. MarketBeat recorded 9 mentions for Enovis and 1 mentions for Envista. Envista's average media sentiment score of 0.40 beat Enovis' score of 0.36 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Enovis	0 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envista has higher revenue and earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.81B	1.41	$47M	$0.41	59.30
Enovis	$2.28B	0.54	-$1.18B	-$19.88	N/A

Summary

Enovis beats Envista on 9 of the 16 factors compared between the two stocks.

How does Enovis compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Enovis (NYSE:ENOV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Enovis has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market.

iRhythm Technologies has higher earnings, but lower revenue than Enovis. iRhythm Technologies is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$787.85M	4.72	-$44.55M	-$0.86	N/A
Enovis	$2.28B	0.54	-$1.18B	-$19.88	N/A

In the previous week, Enovis had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Enovis and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.32 beat Enovis' score of 0.36 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enovis	0 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has a net margin of -3.53% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Enovis	-49.92%	10.32%	4.57%

98.4% of Enovis shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 2.9% of Enovis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

iRhythm Technologies presently has a consensus price target of $187.38, indicating a potential upside of 65.47%. Enovis has a consensus price target of $44.50, indicating a potential upside of 107.68%. Given Enovis' higher possible upside, analysts clearly believe Enovis is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Enovis beats iRhythm Technologies on 9 of the 17 factors compared between the two stocks.

How does Enovis compare to MiniMed Group?

Enovis (NYSE:ENOV) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Enovis presently has a consensus target price of $44.50, indicating a potential upside of 107.68%. MiniMed Group has a consensus target price of $21.33, indicating a potential upside of 40.13%. Given Enovis' higher probable upside, equities research analysts clearly believe Enovis is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

98.4% of Enovis shares are owned by institutional investors. Comparatively, 19.7% of MiniMed Group shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Comparatively, 2.2% of MiniMed Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Enovis had 6 more articles in the media than MiniMed Group. MarketBeat recorded 9 mentions for Enovis and 3 mentions for MiniMed Group. Enovis' average media sentiment score of 0.36 beat MiniMed Group's score of -0.04 indicating that Enovis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	0 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MiniMed Group has a net margin of 0.00% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
MiniMed Group	N/A	N/A	N/A

MiniMed Group has higher revenue and earnings than Enovis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.28B	0.54	-$1.18B	-$19.88	N/A
MiniMed Group	$2.99B	1.43	N/A	N/A	N/A

Summary

Enovis beats MiniMed Group on 7 of the 12 factors compared between the two stocks.

Get Enovis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ENOV vs. The Competition

Export

Metric	Enovis	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.23B	$1.53B	$6.53B	$23.08B
Dividend Yield	N/A	N/A	2.67%	4.10%
P/E Ratio	-1.08	77.41	24.77	30.83
Price / Sales	0.54	6.47	472.99	107.10
Price / Cash	0.89	23.11	43.05	24.20
Price / Book	0.82	4.89	10.49	4.66
Net Income	-$1.18B	-$54.76M	$3.56B	$1.07B
7 Day Performance	-6.25%	-7.19%	-2.12%	-0.33%
1 Month Performance	-13.42%	2.40%	0.59%	0.64%
1 Year Performance	-35.74%	-10.34%	21.80%	20.89%

Enovis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ENOV Enovis	4.159 of 5 stars	$21.43 -2.5%	$44.50 +107.7%	-34.4%	$1.23B	$2.28B	N/A	7,802
VAC Marriott Vacations Worldwide	2.1606 of 5 stars	$90.66 +6.8%	$83.70 -7.7%	+30.2%	$2.92B	$5.03B	N/A	21,100	Gap Up
LIVN LivaNova	1.731 of 5 stars	$73.81 +0.0%	$79.38 +7.5%	+64.7%	$4.05B	$1.43B	37.85	3,300	News Coverage
NVST Envista	2.4822 of 5 stars	$23.34 -0.9%	$28.83 +23.5%	+25.7%	$3.80B	$2.81B	56.93	12,000	Analyst Forecast
IRTC iRhythm Technologies	4.4371 of 5 stars	$109.17 -4.2%	$189.69 +73.8%	-23.3%	$3.74B	$787.85M	N/A	2,400	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ENOV) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enovis (ENOV) Competitors

ENOV vs. VAC, LIVN, NVST, IRTC, and MMED

How does Enovis compare to Marriott Vacations Worldwide?

Summary

How does Enovis compare to LivaNova?

Summary

How does Enovis compare to Envista?

Summary

How does Enovis compare to iRhythm Technologies?

Summary

How does Enovis compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ENOV vs. The Competition

Enovis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enovis (ENOV) Competitors

ENOV vs. VAC, LIVN, NVST, IRTC, and MMED

How does Enovis compare to Marriott Vacations Worldwide?

Do analysts rate ENOV or VAC?

Which has stronger earnings & valuation, ENOV or VAC?

Which has more risk & volatility, ENOV or VAC?

Is ENOV or VAC more profitable?

Do insiders and institutionals have more ownership in ENOV or VAC?

Does the media prefer ENOV or VAC?

Summary

How does Enovis compare to LivaNova?

Does the media prefer ENOV or LIVN?

Which has better valuation and earnings, ENOV or LIVN?

Do analysts rate ENOV or LIVN?

Do insiders and institutionals have more ownership in ENOV or LIVN?

Which has more volatility & risk, ENOV or LIVN?

Is ENOV or LIVN more profitable?

Summary

How does Enovis compare to Envista?

Do analysts recommend NVST or ENOV?

Which has more volatility & risk, NVST or ENOV?

Do insiders & institutionals believe in NVST or ENOV?

Is NVST or ENOV more profitable?

Does the media favor NVST or ENOV?

Which has preferable earnings and valuation, NVST or ENOV?

Summary

How does Enovis compare to iRhythm Technologies?

Which has more risk & volatility, IRTC or ENOV?

Which has stronger earnings & valuation, IRTC or ENOV?

Does the media prefer IRTC or ENOV?

Is IRTC or ENOV more profitable?

Do institutionals & insiders have more ownership in IRTC or ENOV?

Do analysts recommend IRTC or ENOV?

Summary

How does Enovis compare to MiniMed Group?

Do analysts recommend ENOV or MMED?

Do institutionals and insiders believe in ENOV or MMED?

Does the media prefer ENOV or MMED?

Is ENOV or MMED more profitable?

Which has preferable earnings & valuation, ENOV or MMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ENOV vs. The Competition

Enovis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools